(Total Views: 438)
Posted On: 02/27/2020 2:17:09 PM
Post# of 155135
While GNBT is about 15% the MC of CYDY, they seem like a good comparison in some ways of what CYDY can expect with a coronavirus deal and share price response as they are also listed on the OTCQB (currently up 87%).
https://markets.businessinsider.com/news/stoc...1028946781
I would be okay with a $5-10M upfront/milestone deal for coronavirus and 25%+ royalty with no trial or approval expenses. This would bring in much needed awareness, a little money and establish a relationship to build upon for larger deals with cancer, NASH, HIV, etc.
Quote:
The terms of the contract, which have been agreed to in writing by both parties, include an upfront payment of $1 million to initiate the project work in the United States, a $5 million licensing fee for the Ii-Key technology, payment by the Chinese consortium for all costs and expenses related to the development of a COVID-19 vaccine, and a 20% royalty on each dose of vaccine produced.
https://markets.businessinsider.com/news/stoc...1028946781
I would be okay with a $5-10M upfront/milestone deal for coronavirus and 25%+ royalty with no trial or approval expenses. This would bring in much needed awareness, a little money and establish a relationship to build upon for larger deals with cancer, NASH, HIV, etc.
(0)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
